For the past 20 years, the Canadian Pharmacogenomics Network for Drug Safety (CPNDS) has been working to identify why patients have different responses to drug treatments. As part of a recent $200 million Genome Canada initiative, Dr. Bruce Carleton will be leading a new $17 million project to expand on the work of the CPNDS to make medications safer for…
A new approach to drug design can deliver medicine directly to the gut in mice at significantly lower doses than current inflammatory bowel disease treatments.
A pan-Canadian team has developed a new way to quickly find personalized treatments for young cancer patients, by growing their tumours in chicken eggs and analyzing their proteins.
For Media
Every day, our researchers are working towards breakthroughs to transform the lives of kids in British Columbia and around the world. Learn about the latest innovations and advancements in child health.